AIBILI is happy to participate in the Azores Health Summit which will take place on 12-13/05/2022. Our President, Prof. Conceição Lobo, will share AIBILI’s experience in the development and implementation of diabetic retinopathy screening programmes using artificial intelligence. This participation will be complemented by João Diogo Ramos from our partnering company Retmarker SA.
Month: May 2022
US Patent published representing another major milestone in AIBILI’s history (US 11,2354,591 B2)
We are honoured to see our recent US Patent published representing another major milestone in AIBILI’s history. This patent US 11,2354,591 B2 follows the EU Patent EP3289565A1 that was received in August 2020.
The team lead by the inventors José Cunha-Vaz and Torcato Santos have developed a method and device that detects and quantifies abnormal increases of retinal extra cellular space using sites of low optical reflectivity from optical coherence tomography (OCT).
This non-invasive method detects changes in the blood-retinal barrier enabling timely treatment and therapy validation in the early stages of diabetic retinopathy.
Dia Internacional dos Ensaios Clinicos – Investigação Clinica em Portugal
Do not miss the opportunity to hear about AIBILI Data Centre and its relevance for clinical research development.
Carlos Domingues, AIBILI DataCentre Director will participate in this conference taking place on May 19, 2022, in Porto, Portugal.
This AIBILI infrastructure is the unique DataCentre in the Peninsula Iberia certified by ECRIN.
AIBILI has participated in the EATRIS PORTUGAL Hub Meeting on April 27, 2022
AIBILI has participated through his Projects and Tech Transfer Manager, Daniel Sanches Fernandes, in the EATRIS PORTUGAL Hub Meeting on April 27, 2022 at INFARMED, I.P. in Lisbon.
